Viromed Medical AG (ETR:VME)
Germany · Delayed Price · Currency is EUR 5.40
-0.10 (-1.82%)
Last updated: Sep 15, 2026, 5:30 PM CET
Viromed Medical AG Market Cap
Viromed Medical AG has a market cap or net worth of €114.75 million as of September 15, 2026. Its market cap has increased by 79.32% in one year.
Market Cap
114.75M
Enterprise Value
114.39M
Revenue
5.09M
Ranking
n/a
PE Ratio
189.83
Stock Price
€5.40
ChartMarket Cap Chart
Since September 2, 2024, Viromed Medical AG's market cap has increased from 43.74M to 114.75M, an increase of 162.35%. That is a compound annual growth rate of 60.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 114.75M | 49.12% |
| Dec 30, 2025 | 76.95M | 53.23% |
| Dec 30, 2024 | 50.22M | 14.81% |
| Sep 2, 2024 | 43.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 56.91B |
| Bayer Aktiengesellschaft | 47.85B |
| Siemens Healthineers AG | 43.27B |
| Fresenius SE & Co. KGaA | 25.57B |
| MEDICLIN Aktiengesellschaft | 266.00M |
| Medios AG | 249.96M |
| LIMES Schlosskliniken AG | 157.91M |
| Heidelberg Pharma AG | 117.43M |